OpGen, Inc.

OpGen, Inc.verified

OPGN

Price:

$1.75

Market Cap:

$14.62M

OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance (AMR) from bacterial colonies isolated from any specimen, as well as Curetis CE-IVD-marked polymerase chain reaction-based SARS-CoV-2 test kits. The company's products also comprise ARES Technology Platform, including ARES reference database on antimicrobial resistance using next generation sequencing technology and artifici...[Read more]

Industry

Medical - Diagnostics & Research

IPO Date

2015-05-05

Stock Exchange

NASDAQ

Ticker

OPGN

The Enterprise Value as of November 2024 (TTM) for OpGen, Inc. (OPGN) is 27.92M

According to OpGen, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 27.92M. This represents a change of 59.18% compared to the average of 17.54M of the last 4 quarters.

OpGen, Inc. (OPGN) Historical Enterprise Value (quarterly & annually)

How has OPGN Enterprise Value performed in the past?

The mean historical Enterprise Value of OpGen, Inc. over the last ten years is 121.85M. The current 27.92M Enterprise Value has changed 2.19% with respect to the historical average. Over the past ten years (40 quarters), OPGN's Enterprise Value was at its highest in in the March 2015 quarter at 522.59M. The Enterprise Value was at its lowest in in the December 2019 quarter at 5.14M.

Quarterly (TTM)
Annual

Average

121.85M

Median

57.37M

Minimum

14.28M

Maximum

521.93M

OpGen, Inc. (OPGN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of OpGen, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 122.83%

Maximum Annual Enterprise Value = 521.93M

Minimum Annual Increase = -75.18%

Minimum Annual Enterprise Value = 14.28M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202315.20M6.42%
202214.28M-44.58%
202125.77M-38.23%
202041.72M122.83%
201918.72M-75.18%
201875.44M3.32%
201773.01M-63.55%
2016200.33M-13.68%
2015232.08M-55.53%
2014521.93M0.68%

OpGen, Inc. (OPGN) Average Enterprise Value

How has OPGN Enterprise Value performed in the past?

The current Enterprise Value of OpGen, Inc. (OPGN) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

18.42M

5-year avg

23.14M

10-year avg

121.85M

OpGen, Inc. (OPGN) Enterprise Value vs. Peers

How is OPGN’s Enterprise Value compared to its peers?

OpGen, Inc.’s Enterprise Value is greater than Bone Biologics Corporation (372.73K), greater than NanoVibronix, Inc. (-452705.00), greater than Bluejay Diagnostics, Inc. (-6409922.00), greater than Vivos Therapeutics, Inc. (7.68M), greater than Tivic Health Systems, Inc. (-1899758.00), greater than Heart Test Laboratories, Inc. (-834267.00), greater than NeuroMetrix, Inc. (6.29M), greater than ReShape Lifesciences Inc. (2.13M), greater than Inspira Technologies Oxy B.H.N. Ltd. (19.23M), less than Sight Sciences, Inc. (151.28M), greater than STRATA Skin Sciences, Inc. (22.33M), less than NeuroPace, Inc. (246.80M), less than Vapotherm, Inc. (133.30M), greater than Talis Biomedical Corporation (-37931750.00), greater than Nuwellis, Inc. (4.84M), greater than Nemaura Medical Inc. (19.51M), greater than Movano Inc. (9.28M), greater than INVO Bioscience, Inc. (7.69M), less than enVVeno Medical Corporation (42.68M),

Build a custom stock screener for OpGen, Inc. (OPGN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like OpGen, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

OpGen, Inc. (OPGN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like OpGen, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is OpGen, Inc.'s Enterprise Value?

What is the highest Enterprise Value for OpGen, Inc. (OPGN)?

What is the 3-year average Enterprise Value for OpGen, Inc. (OPGN)?

What is the 5-year average Enterprise Value for OpGen, Inc. (OPGN)?

How does the current Enterprise Value for OpGen, Inc. (OPGN) compare to its historical average?